AGÕæÈ˹ٷ½

STOCK TITAN

Leaders Come Together to Advance the Industry at Veeva Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Veeva Systems (NYSE:VEEV) has announced details for its upcoming R&D and Quality Summit, scheduled for September 3-4 in Boston. The event will bring together over 2,000 life sciences professionals from leading companies including Alnylam, BeOne Medicines, Intercept, Merck, Pfizer, and Sanofi.

A key highlight will be the showcase of Veeva AI, built into the Vault Platform with secure access to data, documents, and workflows. The summit will feature more than 100 sessions focusing on accelerating development, manufacturing processes, and improving trial oversight. Notable case studies include Merck's clinical operations streamlining, FUJIFILM Biotechnologies' global quality management implementation, and Sanofi's study training optimization.

Veeva Systems (NYSE:VEEV) ha comunicato i dettagli del suo prossimo R&D and Quality Summit, in programma il 3 e 4 settembre a Boston. L'evento riunirà oltre 2.000 professionisti delle scienze della vita provenienti da aziende di primo piano come Alnylam, BeOne Medicines, Intercept, Merck, Pfizer e Sanofi.

Uno dei punti salienti sarà la presentazione di Veeva AI, integrata nella Vault Platform con accesso sicuro a dati, documenti e flussi di lavoro. Il summit proporrà più di 100 sessioni dedicate ad accelerare sviluppo e processi produttivi e a migliorare la sorveglianza dei trial. Tra i case study in evidenza: l'ottimizzazione delle operazioni cliniche di Merck, l'implementazione globale della gestione qualità di FUJIFILM Biotechnologies e la razionalizzazione della formazione agli studi di Sanofi.

Veeva Systems (NYSE:VEEV) ha anunciado los detalles de su próximo R&D and Quality Summit, que se celebrará los días 3 y 4 de septiembre en Boston. El evento reunirá a más de 2.000 profesionales de las ciencias de la vida de compañías líderes como Alnylam, BeOne Medicines, Intercept, Merck, Pfizer y Sanofi.

Uno de los principales atractivos será la demostración de Veeva AI, integrada en la Vault Platform con acceso seguro a datos, documentos y flujos de trabajo. El summit contará con más de 100 sesiones centradas en acelerar el desarrollo y los procesos de fabricación, y en mejorar la supervisión de los ensayos. Entre los casos destacados figuran la optimización de las operaciones clínicas de Merck, la implantación global de la gestión de calidad de FUJIFILM Biotechnologies y la mejora de la formación para estudios de Sanofi.

Veeva Systems (NYSE:VEEV)ê°€ 9ì›� 3~4ì� 보스턴ì—ì„� 열리ëŠ� R&D and Quality Summitì� 세부 ì¼ì •ì� 발표했습니다. ì� 행사ëŠ� Alnylam, BeOne Medicines, Intercept, Merck, Pfizer, Sanofi ë“� 주요 기업ì� 2,000ëª� ì´ìƒì� ìƒëª…과학 전문가ë¥� 한ìžë¦¬ì— ëª¨ì„ ì˜ˆì •ìž…ë‹ˆë‹�.

주요 볼거리는 ë°ì´í„�, 문서 ë°� 워í¬í”Œë¡œì—� 대í•� 안전í•� ì ‘ê·¼ì� í¬í•¨ë� Vault Platform ë‚´ì˜ Veeva AI 시연입니ë‹�. 서밋ì—서ëŠ� 개발 ê°€ì†í™”, 제조 공정 개선 ë°� ìž„ìƒ ì‹œí—˜ ê°ë… ê°•í™”ë¥� 주제ë¡� í•� 100ê°� ì´ìƒì� 세션ì� 열립니다. 주목í•� 만한 사례로는 Merckì� ìž„ìƒ ìš´ì˜ ê°„ì†Œí™�, FUJIFILM Biotechnologiesì� 글로벌 품질 ê´€ë¦� ë„ìž…, Sanofiì� 스터ë”� êµìœ¡ 최ì í™”ê°€ í¬í•¨ë©ë‹ˆë‹�.

Veeva Systems (NYSE:VEEV) a dévoilé les détails de son prochain R&D and Quality Summit, prévu les 3 et 4 septembre à Boston. L'événement rassemblera plus de 2 000 professionnels des sciences de la vie issus d'entreprises de premier plan telles qu'Alnylam, BeOne Medicines, Intercept, Merck, Pfizer et Sanofi.

Un point fort sera la présentation de Veeva AI, intégrée à la Vault Platform avec un accès sécurisé aux données, documents et flux de travail. Le sommet proposera plus de 100 sessions axées sur l'accélération du développement et des processus de fabrication, ainsi que sur l'amélioration de la supervision des essais. Parmi les études de cas notables: la rationalisation des opérations cliniques chez Merck, le déploiement mondial de la gestion qualité par FUJIFILM Biotechnologies et l'optimisation de la formation aux études chez Sanofi.

Veeva Systems (NYSE:VEEV) hat die Details zu seinem bevorstehenden R&D and Quality Summit bekanntgegeben, der am 3. und 4. September in Boston stattfindet. An der Veranstaltung werden über 2.000 Fachleute aus den Lebenswissenschaften von führenden Unternehmen wie Alnylam, BeOne Medicines, Intercept, Merck, Pfizer und Sanofi teilnehmen.

Ein zentrales Highlight wird die Vorstellung von Veeva AI sein, integriert in die Vault Platform mit sicherem Zugriff auf Daten, Dokumente und Workflows. Der Summit umfasst mehr als 100 Sessions, die sich auf die Beschleunigung von Entwicklung und Herstellungsprozessen sowie auf die Verbesserung der Trial-Überwachung konzentrieren. Hervorzuhebende Fallstudien sind Mercks Straffung der klinischen Abläufe, die globale Implementierung des Qualitätsmanagements bei FUJIFILM Biotechnologies und Sanofis Optimierung der Studien-Schulungen.

Positive
  • None.
Negative
  • None.

Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction

Veeva to showcase innovations, including deep industry-specific Veeva AI in Vault Platform and Veeva applications

PLEASANTON, Calif., Aug. 21, 2025 /PRNewswire/ -- (NYSE: VEEV) today announced highlights of its upcoming , where leaders across life sciences and Veeva exchange impactful ideas and innovations. BeOne Medicines, Intercept Pharmaceuticals, Merck, and Pfizer are among the leaders coming together September 3-4 in Boston to share how they are advancing clinical, regulatory, safety, and quality.

Veeva will highlight advancements in software, data, and business consulting, including . The AI for life sciences, Veeva AI is built into the Vault Platform with direct and secure access to Vault data, documents, and workflows. Customers will learn more about the deep Veeva AI Agents being delivered for Veeva applications and how they can use Veeva AI to create their own custom agents.

More than 100 Veeva R&D and Quality Summit sessions showcase the latest advances and inspire new thinking, including:

Accelerating development and manufacturing by connecting systems and processes

  • Merck streamlines clinical with unified operations and data management and standardizes data cross-functionally with a single pharmacovigilance platform.

  • FUJIFILM Biotechnologies moves from a site-based approach to a global quality management system to drive consistency for greater visibility and control.

  • BeOne Medicine modernizes regulatory, increasing efficiency and strengthening compliance with multi-health authority submissions.

Improving trial oversight and collaboration among sites, sponsors, and CROs

  • Immunovant improves study oversight in outsourced trials with real-time access to CRO data to save time and prevent errors.

  • Sanofi streamlines study training with a single, inspection-ready solution, eliminating disconnected systems across study teams and site staff.

  • Memorial Sloan Kettering Cancer Center (MSK) improves engagement with sponsors and CROs and shares a site perspective.

"Leaders come to Veeva R&D and Quality Summit eager to share their experiences knowing that new ideas can be the difference in getting needed medicines to patients faster. This openness helps the entire community to learn from each other and move the industry forward," said Jim Reilly, president of Veeva Development Cloud.

At Veeva R&D and Quality Summit, more than 2,000 attendees will exchange ideas with colleagues. The event is open exclusively to life sciences professionals who can register and stay up to date on the agenda at .

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a , Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit .

Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2025, which you can find  (a summary of risks which may impact our business can be found on pages 32 and 33), and in our subsequent SEC filings, which you can access at .

Contact:

Deivis Mercado
Veeva Systems
925-226-8821
[email protected]

Cision View original content to download multimedia:

SOURCE Veeva Systems

FAQ

When and where is the Veeva R&D and Quality Summit 2025 taking place?

The Veeva R&D and Quality Summit is taking place on September 3-4, 2025 in Boston.

What companies will be presenting at Veeva's 2025 Summit?

Key presenting companies include Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, Sanofi, FUJIFILM Biotechnologies, Immunovant, and Memorial Sloan Kettering Cancer Center.

What is Veeva AI and how will it be featured at the Summit?

Veeva AI is a life sciences-specific AI system built into the Vault Platform with secure access to Vault data, documents, and workflows. The Summit will showcase deep Veeva AI Agents for Veeva applications and demonstrate how customers can create custom agents.

How many sessions and attendees are expected at the 2025 Veeva Summit?

The Summit will feature more than 100 sessions and is expected to attract over 2,000 attendees from the life sciences industry.
Veeva Sys Inc

NYSE:VEEV

VEEV Rankings

VEEV Latest News

VEEV Latest SEC Filings

VEEV Stock Data

46.47B
149.44M
8.55%
89.79%
2.83%
Health Information Services
Services-prepackaged Software
United States
PLEASANTON